EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Callaghan, Gavin B.
Shah, Ayesha
Fairlie, Thomas
Jones, Michael P.
Holtmann, Gerald J.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1142
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [41] Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis
    Singh, Anupam Kumar
    Jha, Daya Krishna
    Jena, Anuraag
    Kumar-M, Praveen
    Sebastian, Shaji
    Sharma, Vishal
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E564 - E573
  • [42] Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis
    Singh, Anupam Kumar
    Jha, Daya Krishna
    Jena, Anuraag
    Kumar-M, Praveen
    Sebastian, Shaji
    Sharma, Vishal
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E564 - E573
  • [43] Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Khan, Khurram J.
    Dubinsky, Marla C.
    Ford, Alexander C.
    Ullman, Thomas A.
    Talley, Nicholas J.
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 630 - 642
  • [44] SAFETY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE AMONG SOLID ORGAN TRANSPLANT RECIPIENTS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Taneja, Vikas
    Anand, Rajsavi
    El-Dallal, Mohammed
    Dong, Jeffrey
    Desai, Nisa
    Taneja, Isha
    Feuerstein, Joseph D.
    GASTROENTEROLOGY, 2022, 162 (07) : S820 - S820
  • [45] Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
    O'Toole, Aoibhlinn
    Alakkari, Alaa
    Keegan, Denise
    Doherty, Glen
    Mulcahy, Hugh
    O'Donoghue, Diarmuid
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 439 - 441
  • [46] Sclerosing cholangitis in inflammatory bowel disease:: diagnosis and therapy
    Broomé, U
    IBD AND SALICYLATES - 5, 2001, 24 (01): : 181 - 190
  • [47] PRIMARY SCLEROSING CHOLANGITIS RECURRENCE AFTER LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Numan, Laith
    Al Momani, Laith
    Husainat, Nedaa M.
    Nehme, Fredy
    Hamdeh, Shadi
    GASTROENTEROLOGY, 2020, 158 (06) : S1344 - S1344
  • [48] Association between appendectomy and risk of primary sclerosing cholangitis: A systematic review and meta-analysis
    Wijarnpreecha, Karn
    Panjawatanan, Panadeekarn
    Mousa, Omar Y.
    Cheungpasitporn, Wisit
    Pungpapong, Surakit
    Ungprasert, Patompong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (05) : 436 - 442
  • [49] Association between smoking and risk of primary sclerosing cholangitis: A systematic review and meta-analysis
    Wijarnpreecha, Karn
    Panjawatanan, Panadeekarn
    Mousa, Omar Y.
    Cheungpasitporn, Wisit
    Pungpapong, Surakit
    Ungprasert, Patompong
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (04) : 500 - 508
  • [50] SAFETY AND EFFICACY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE IN LIVER TRANSPLANT RECIPIENTS FOR PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER EXPERIENCE
    Mousa, Omar Y.
    Tse, Chung Sang
    Sanchez, William
    Keaveny, Andrew Paul
    Kamath, Patrick S.
    Harnois, Denise M.
    Carey, Elizabeth J.
    Picco, Michael F.
    Loftus, Edward V.
    Leighton, Jonathan A.
    Lazaridis, Konstantinos N.
    Watt, Kymberly
    Eaton, John E.
    HEPATOLOGY, 2019, 70 : 702A - 703A
12345